Journal Home     Contents    Preview    Next

Results of Surgical Treatment of Ear Canal and
Middle Ear Carcinoma

Milan Stankovic

Clinic of Otorhinolaryngology, Medical Faculty Nis, Serbia, Yugoslavia

ABSTRACT

Hypothesis: There is a difference in clinical characteristics and results of surgical treatment for primary and secondary temporal bone carcinoma.
Background: Carcinoma of temporal bone is rare, but it has considerable malignant potential. Carcinoma of external ear canal is less aggressive and has bigger five-year survival rate than the carcinoma of middle ear. Critical evaluation of therapeutical results of these tumours is difficult because of unequal classification.
Methods: To analyse the results of surgical and radiation therapy of these carcinomas we divided them into primary (9 patients) and secondary tumors (12 patients) according to Arriaga et al. (1990). Partial temporal bone resection was done in 7 patients, subtotal resection (petrosectomy) in 11 and total temporal bone resection in 2 patients. Postoperative irradiation during 6 weeks with 6 000 cGy in 30 fractions was also applied.
Results: Five-year survival rate for primary carcinoma decreased from 100% for grade A, to 33% for group B, and to 0% for group C. For secondary carcinoma this rate decreased from 75%, to 66%, and finally to 0% for the same clinical groups.
Conclusion: Prognosis of temporal bone carcinoma directly depends on the propagation of tumour. Computerised tomo-graphy is a reliable method for determination of the propagation and for planning the treatment. Temporal bone resection with postoperative irradiation is the method of choice of temporal bone carcinoma. Significant differences in clinical characteristics between primary and secondary invasive temporal bone tumors were found. Adequate selection of patients, choice of surgical resection, reconstruction and postoperative radiotherapy can achieve better survival rate, and can improve patient's quality of life.
Key words: External auditory meatus, Middle ear, Surgical treatment, Cancer.
Pro Otology 2: 55-60, 2002


INTRODUCTION

Temporal bone tumors can be histologically benignant (adenoma, invert papilloma, meningeoma) and malignant. Malignant temporal bone tumors can be divided on primary (planocellular carcinoma, adenocarcinoma), metastatic (from breast, lungs, kidney, stomach, larynx) and secondary affection (basocellular and planocellular carcinoma, other carcinoma and sarcoma).

Temporal bone carcinoma is a rare disease, but it has very aggressive course and bad prognosis. Clinical presentation of temporal bone tumor is usually insufficiently specific, and when it is obvious the disease is advanced with rapid progression and limited therapeutic success. One of the reasons for insufficient results of their therapy is because diagnosis of malignancy is verified in the late stage. The classification of temporal bone carcinoma is not universally accepted. This makes adequate selection of therapeutic modalities very problematic. Different surgical techniques for temporal bone resection are developed, but their success is difficult to access (1-3).

The aim of this study was to analyze the clinical characteristics, surgical results of a series of patients who underwent surgical therapy for primary and secondary temporal bone tumor.

 

Table 1. Classification of external auditory meatus and middle ear malignant tumors.
TNM CLASSIFICATION CLINICAL CLASSIFICATION
T1 - limited tumor without bone erosion,

T2 - local propagation through preformed pathways

T3 - local affection of external canal and middle ear

T4 - erosion of cochlea, petrous apex, dura,

T1N1 - stage III, T2-4 N1 - stage IV
A - limited lesion to auditory meatus and middle ear, no bone erosion,

B - affection of bony structures of meatus and middle ear,

C - affection of cochlea, dura, petrous apex and more advanced process.

 

FIG. 1. Computerised tomography of temporal bone carcinoma: 1) Primary carcinoma, 2) Intra-cranial propagation, 3) Status after operation of secondary carcinoma, 4) and 5) Finding after subtotal petrosectomy, 6) reconstruction after resection of secondary temporal bone carcinoma.

 

METHODS

Between 1985 and 1994, 21 patients with malignant tumors of the external auditory canal and middle ear were treated at the Department of Otolaryngology, University Medical faculty Nis. Their hospital charts were retrospectively reviewed. They were divided in the groups with primary (9 patients) and secondary (12 patients) temporal bone tumors. Secondary tumors stared on auricle, its surroundings and parotid gland. The CT scans were used to analyze the extent of tumor. The stage of disease was determined according to Arriaga et. al. (1990) (4) (Table 1).

Partial temporal bone resection, subtotal resection (petrosectomy) or total temporal bone re-sections were surgical methods of treatment. Postoperative irradiation with 6 000 cGy during 6 weeks in 30 fractions was applied in all the patients.

Clinical characteristics, types of operation and survival rate were analysed and compared in primary and secondary group of temporal bone tumors.

RESULTS

There were 17 males and 4 females, and their ages ranged from 37 to 79 years (median: 66). Sex distribution was nearly equal in the group of primary tumors (male: female ratio 5:4), contrary to secondary temporal bone involvement where males significantly predominated (male: female ratio 11:1).

Otalgia, otorrhea or bloody otorrhea were the chief complaints of most patients with external auditory canal of middle ear tumors (Table 2). Most of the patients with primary tumors present at an advanced stage of the disease. In four patients the tumor had destroyed surrounding bone, involving the endocranium in two, in five the facial nerve was paralysed and in seven patients there was total hearing loss. The diagnosis of malignant tumor was established before surgery in five patients, but four patients were operated upon for suspected chronic otitis.

External auditory canal tumors were surgically excised, while radical mastoidectomy, subtotal, or total petrosectomy and subsequent irradiation were performed for the middle ear tumors. Patohistological examination revealed squamous cell carcinoma in all the cases (Table 3).

Secondary affection of bony external meatus and middle ear was the result of local invasiveness of planocellular (58%) or basocellular carcinoma (42%), or inadequate previous surgical therapy. Namely, all the patients in this series were previously surgically treated. Local recidive was mainly situated on one of the borders of tumor, and in one case operated by plastic surgeon residual tumor was present deeply in meatus, together with tympanic membrane, both covered by local skin flap.

Metastatic temporal bone tumor was verified in one patient. She was 69 years old with intense local pain, pressure, left hearing loss, vertigo, and no previous ear disease. Twelve years age she had gastrectomy with histologically proven adenocarcinoma. On otoscopy tympanic membrane was intact, she had mixed hearing loss at 50-60 dB. Classical Schuller radiography indicated on osteolytic area 4x3 cm in squamous and mastoid part of temporal bone. Subtotal temporal bone resec-tion was performed and metastatic temporal bone tumor, adenocarcinoma was verified. After that postoperative irradiation was performed, but lethal exitus occurred seven months later because of intracranial propagation.

Table 4. shows the survival according to pathologic extent of lesion and the involvement of tissue margins. For primary temporal bone malignances survival amounted 100% for the group A, 33% for the group B, and 0% for the group C. For secondary tumor involvement this rate amounted 75%, 66%, and 0%, respectively. In both groups patients with free margins had significantly better survival rate (totally 82%), than patients with involved margins (0%). Also, patients with affected lymph nodes had very poor survival rate (19%).

Local recurrence of tumor was the cause of death in all such cases, with the average interval from recurrence to death amounting 4,1 month.

The extent of surgery did not affect the survival rate when comparing partial resection and subtotal petrosectomy. Total temporal bone resection was not sufficient because of tumor propagation in cases where this operation was performed (Table 5, Histogram 1).

 

Table 2. Clinical presentation of patients with temporal bone malignances.
SYMPTOMS PRIMARY TUMOR SECONDARY TUMOR
Otorrhoea 9 (100%) 5 (42%)
Hearing loss 9 (100%) 5 (42%)
Bleeding 6 (67%) 6 50%)
Pain 5 (56%) 10 (83%)
Facial paralysis 5 (56%) 4 33%)
Vertigo 4 (44%) 4 (33%)
Soft tissue affection 0 (0%) 12 (100%)

  Table 3. Surgical treatment of patients with temporal bone malignances.
OPERATION PRIMARY TUMOR SECONDARY TUMOR
Previous operation 0 (0%) 12 (100%)
Radical trepanation 2 (22%) 5 (42%)
Subtotal petrosectomy 4 (44%) 7 (58%)
Total petrosectomy 2 (22%) 0 (0%)
Parotidectomy 2 (22%) 3 25%)
Neck dissection 2 (22%) 4 (33%)
Soft tissue resection 0 (0%) 12 (100%)
Reoperation 0 (0%) 4 (33%)

 

DISCUSSION

Early detection of primary temporal bone tumor relies on histopathologic analyze of each removed external canal and middle ear tissue. This should be followed by detailed high-resolution computerized tomography (CT) for documentation of bone erosion. Soft tissue changes can not be accurately verified only on the basis of CT scan, so MRI must be used as an adjunct diagnostic procedure in some cases (5).

Long-standing chronic otitis media usually preceeds the malignant process of temporal bone, however this was not common for primary malignances in our analyze. Otologists should bear in mind this disease in patients with chronic suppurative otitis and accompanying suspected symptoms (6).

Extension of tumor is associated with higher mortality rate. Local invasion of tumor is the most important prognostic factor. This emphasizes the need for adequate preoperative diagnosis, and surgical technique that enables resection of tumor that leaves margins unaffected.

Patterns of temporal bone tumor invasion are: superior erosion through the tegmen tympani into the middle cranial fossa, anteriorly into the glenoid fossa and infratemporal space, inferiorly through jugular foramen, posteriorly in the mastoid air cells, medially into carotid canal, and very rarely through otic capsule erosion (7). We found endocranial and skull base propagation to be the most frequent and the most important.

 

Table 4. Five year survival of patients with temporal bone malignances and histologic margins.
 

GROUP
PRIMARY TUMOR *

Margins

free involved
SECONDARY TUMOR

Margins

free involved
Group A 2/2 (100%) - 3/3 (100%) 0/1 (0%)
Group B 1/1 (100%) 0/2 (0%) 3/4 (75%) 1/2 (50%)
Group C 0/1 (0%) 0/2 (0%) - 0/2 (0%)
*One patient with primary tumor was treted only by radiotherapy.
 
Table 5. Five year survival of patients with temporal bone malignances and type of surgery.
OPERATION PRIMARY TUMOR * SECONDARY TUMOR
Partial resection 1/2 (50%) 4/5 (80%)
Subtotal petrosectomy 2/4 (50%) 3/7 (43%)
Total petrosectomy 0/2 (0%) -
*One patient with primary tumor was treted only by radiotherapy.
 

 

Metastatic carcinoma of the temporal bone is rare and usually not recognized because it can be oligosymptomatic or overshadowed by other metastases. Also, metastatic evaluation does not include temporal bone imaging (8,9).

Classification of temporal bone malignances is very important for planning and performing surgical treatment. Their categorization can be according to the site of origin, histopathologic type and local invasiveness of tumor (4). Staging system proposed by Arriaga for external canal tumors can be used for middle ear tumors as well. This is because external meatus tumors universally spread to middle ear, and further propagation is the same.

The surgical treatment of temporal bone malignancies is strictly dependent upon the radiographic delineation of disease extent and the tumor relationship to adjacent neurovascular structures.

Petrosectomy has been used in the management of carcinoma of the external ear canal and the middle ear for the last half of century. There is some controversy concerning choice of their surgical treatment. Some otologists propose a conservative approach, whereas others support an ultra-radical approach.

Extended temporal bone resection with supraomohyoid block dissection, dural grafting, and free microvascular forearm or scalp rotation flap repair gives the best 5-year survival. According to some studies radical surgery combined with radiotherapy may give much better survival than the conventional partial temporal bone resection and radiotherapy (11-16). Although radiotherapy was used postoperatively, the problems of wound healing were not addressed.

The importance of clinical studies that compare different classifications of temporal bone tumors is in better planning of surgical therapy, evaluation of efficacy of treatment and comparison of survival rate. The five-year survival rate of temporal bone tumors determined by the Kaplan-Meier method is differently reported in literature, mainly because of differences in extention of tu-mor and small number of cases. In general, external auditory canal tumors have twice as bigger survival rate than for middle ear tumors.

No randomized or nonrandomized control studies are present in medical literature concerning primary or secondary temporal bone malignances. Usually, all studies are case series without control subjects. Review of articles dealing with surgical therapy of such tumors indicates on the following data. Patients with carcinoma that is confined to the external auditory canal have similar survival, regardless of whether mastoidectomy, lateral temporal bone resection, or subtotal temporal bone resection is performed. The addition of radiation therapy to lateral temporal bone resection does not appear to improve survival. When tumor extends into the middle ear, survival of patients treated with subtotal temporal bone resection appeared to be improved over those treated with lateral resection or mastoidectomy. Additional radiation therapy to mastoidectomy improves survival, but the exact value is uncertain. The results of surgical resection when carcinoma extends from middle and inner ear and involves the petrous apex are bad. Resection of involved dura mater, in-volved brain parenchyma or internal carotid artery is of limited or no clinical improvement.

The best survival rate is obtained with total temporal bone resection and postoperative radiotherapy. However, this technique can not be used for all the patients. In some cases the risk of such operation is high, resectability of tumor is doubtful, or there is significant risk for persistent CSF leak, or there is endocranial propagation. All parts of temporal bone are not affected with tu-mor, so in some patients preservation of some bone trabecula can be advantageous.

According to the results of this study there are some clinically important differences be-tween primary and secondary temporal bone tumors. Secondary malignancy is mainly caused by locally invasive or inadequately radically operated tumor starting around external meatus. Thus, their diagnosis is obvious, previous operation is frequent, and reoperation can be performed if nec-essary. Basocellular carcinoma usually infiltrates at few sites, so reoperations are necessary, but their survival rate (60%) is much better than for planocellular carcinoma (43%). Primary tumors are frequently unexpectedly found, adequate preoperative diagnosis can be wrong, and reoperations can be hardly performed. Affection of middle ear is followed by further propagation inside temporal bone and adjacent vital structures, so there are very little differences in survival in such stage no matter type of tumor, or type of surgical procedure.

CONCLUSION

Prognosis of temporal bone carcinoma is directly related to the extension of tumor. Early diagnosis is needed for adequate, successful therapy. Computerized tomography delineates precisely the extension of tumor and improves planning of therapy. Therapy of temporal bone carcinoma is combined: surgical and irradiation, however the five year survival is poor. Significant differences in clinical characteristics between primary and secondary invasive temporal bone tumors were found.

Adequate selection of patients, choice of surgical resection, reconstruction and postoperative radiotherapy can achieve better survival rate, and can improve patient's quality of life.

REFERENCES

  1. Hahn SS, Kim JA, Goodchild N, Constable WC. Carcinoma of the middle ear and external auditory canal. Int J Radiat Oncol Biol Phys 1983;9:1003-7.

  2. Kuhel WI, Hume CR, Selesnick SH. Cancer of the external auditory canal and temporal bone. Otolaryngol Clin North Am 1996;29:827-52.

  3. Lustig LR, Jackler RK, Lanser MJ. Radiation-induced tumors of the temporal bone. Am J Otol 1997;18:230-5.

  4. Arriaga M, Curtin H, Takahashi H, Hirsch B, Kamerer D. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 1990;99:714-21.

  5. Pensak ML, Gleich LL, Gluckman JL, Shumrick KA. Temporal bone carcinoma: contemporary perspectives in the skull base surgical era. Laryngoscope 1996;106:1234-7.

  6. Savic D, Djeric D. Malignant tumours of the middle ear. Clin Otolaryngol 1991;16:87-9.

  7. Leonetti JP, Smith PG, Kletzker GR, Izquierdo R. Invasion patterns of advanced temporal bone malignancies. Am J Otol 1996;17:438-42.

  8. Streitmann MJ, Sismanis A. Metastatic carcinoma of the temporal bone. Am J Otol 1996;17:780-3.

  9. Weiss MD, Kattah JC, Jones R, Manz HJ. Isolated facial nerve palsy from metastasis to the temporal bone: report of two cases and a review of the literature. Am J Clin Oncol 1997;20:19-23.

  10. Prasad S, Janecka IP. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg 1994;110:270-80.

  11. Tiwari R, Feenstra L, Karim A. Temporal bone resections for carcinoma of the middle ear and the external ear canal. Am J Surg 1992;164:648-50.

  12. Paaske PB, Witten J, Schwer S, Hansen HS. Results in treatment of carcinoma of the external auditory canal and middle ear. Cancer 1987;59:156-60.

  13. Gabriele P, Magnano M, Albera R, Canale G, Redda MG, Krengli M, Negri GL. Carcinoma of the external auditory meatus and middle ear. Results of the treatment of 28 cases. Tumori 1994;80:40-3.

  14. Moffat DA, Grey P, Ballagh RH, Hardy DG. Extended temporal bone resection for squamous cell carcinoma. Otolaryngol Head Neck Surg 1997;116:617-23.

  15. Mohri M, Nagashima T, Tahara S, Amatsu M. Significance of tubal resection in surgical treatment of middle ear carcinoma. Eur Arch Otorhinolaryngol 1997;254:208-11.

  16. Arena S, Keen M. Carcinoma of the middle ear and temporal bone. Am J Otol 1988;9:351-5.


  Journal Home     Contents    Preview    Next